Phreesia, Inc. (PHR) Balance Sheet

As of 2026-07-31 (10-Q), Phreesia, Inc. (PHR) reported total assets of $647.0M, total liabilities of $275.1M and shareholders' equity of $371.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $74.6M. Long-term debt: $1.1M.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

PHRPhreesia, Inc.Follow PHR — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 788.3M
P/E TTM: 74.7
Dividend yield: —
52-week: —
Next earnings: 7 Dec, in 44 days

Line	FY2020 Jan 20	FY2021 Jan 21	FY2022 Jan 22	FY2023 Jan 23	FY2024 Jan 24	FY2025 Jan 25	FY2026 Jan 26	Latest Jul 26
Cash and equivalents	90.3	218.8	313.8	176.7	87.5	84.2	73.8	74.6
Receivables	22.0	29.1	40.3	51.4	64.9	73.6	97.5	89.4
Current assets	131.5	272.3	386.3	262.4	195.7	203.3	279.8	253.5
Total assets	158.8	326.7	494.5	370.1	370.3	388.4	663.8	647.0
Current liabilities	35.4	55.0	68.4	79.0	110.1	114.0	183.2	143.8
Long-term debt	21.5	6.5	7.4	0.2	3.1	1.9	2.7	1.1
Short-term debt	2.3	4.9	5.8	5.2	6.1	8.0	8.0	5.3
Total liabilities	56.9	63.4	77.2	82.2	118.9	123.6	326.6	275.1
Shareholders' equity	101.9	263.3	417.3	287.8	251.4	264.8	337.2	371.9

USD millions · SEC XBRL

Phreesia, Inc. — questions

How much cash does Phreesia, Inc. have?: $74.6M in cash and cash equivalents as of 2026-07-31.
How much debt does Phreesia, Inc. have?: $1.1M of long-term debt and $5.3M due within a year as of 2026-07-31.
What are Phreesia, Inc.'s total assets?: $647.0M as of 2026-07-31.
What is Phreesia, Inc.'s shareholders' equity?: $371.9M as of 2026-07-31.

Every figure on this page comes from Phreesia, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.